EA200702479A1 - Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов - Google Patents

Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов

Info

Publication number
EA200702479A1
EA200702479A1 EA200702479A EA200702479A EA200702479A1 EA 200702479 A1 EA200702479 A1 EA 200702479A1 EA 200702479 A EA200702479 A EA 200702479A EA 200702479 A EA200702479 A EA 200702479A EA 200702479 A1 EA200702479 A1 EA 200702479A1
Authority
EA
Eurasian Patent Office
Prior art keywords
violation
prevention
treatment
active composition
work
Prior art date
Application number
EA200702479A
Other languages
English (en)
Inventor
Жан-Кристоф Антон
Original Assignee
Персе Медика
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Персе Медика filed Critical Персе Медика
Publication of EA200702479A1 publication Critical patent/EA200702479A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к активной композиции для лечения или профилактики проблем, вызванных нарушением работы биологических часов человека, содержащей полиненасыщенные жирные кислоты и флавоноиды в качестве активных компонентов.
EA200702479A 2005-05-13 2006-05-12 Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов EA200702479A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0551254A FR2885528A1 (fr) 2005-05-13 2005-05-13 Composition utile pour traiter ou prevenir les troubles lies a un dereglement de l'horloge biologique
PCT/FR2006/001079 WO2006120360A2 (fr) 2005-05-13 2006-05-12 Composition pour traiter ou prevenir les troubles liés à un dérèglement de l'horloge biologique

Publications (1)

Publication Number Publication Date
EA200702479A1 true EA200702479A1 (ru) 2008-04-28

Family

ID=35423717

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702479A EA200702479A1 (ru) 2005-05-13 2006-05-12 Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов

Country Status (7)

Country Link
US (1) US20090069425A1 (ru)
EP (1) EP1879621A2 (ru)
CA (1) CA2608060A1 (ru)
EA (1) EA200702479A1 (ru)
FR (1) FR2885528A1 (ru)
NO (1) NO20076426L (ru)
WO (1) WO2006120360A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3485894B1 (en) * 2017-11-20 2021-01-06 Italfarmaco SpA Combination of officinal plants and their use in the treatment and/or prevention of sleep disorders
JP2020031570A (ja) * 2018-08-29 2020-03-05 大正製薬株式会社 体内時計調整用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
US20020068100A1 (en) * 2000-10-12 2002-06-06 Bioriginal Food & Science Corporation Combination therapy for premenstrual symptoms
FR2815227B1 (fr) * 2000-10-17 2003-04-11 Schwartz Laboratoires Robert Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
US6391346B1 (en) * 2001-04-05 2002-05-21 Thomas Newmark Anti-inflammatory, sleep-promoting herbal composition and method of use
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
US7258922B2 (en) * 2003-03-31 2007-08-21 Thi International, Inc. Compositions, methods and devices for enhancing landscaping or marker materials
DE10255481A1 (de) * 2002-11-28 2004-06-17 Dr. Loges + Co. Gmbh Arzneimittel Pharmazeutische Zubereitungen umfassend mittels Extraktion mit überkritischen Flüssigkeiten hergestellte Hopfenextrakte zur Verwendung als Sedativa
DE10315025A1 (de) * 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Wirkstoffkombination von ω3-fettsäurehaltigen Ölen mit polyphenolhaltigen Pflanzenextrakten und deren Verwendung

Also Published As

Publication number Publication date
WO2006120360A2 (fr) 2006-11-16
WO2006120360A3 (fr) 2007-11-08
CA2608060A1 (fr) 2006-11-16
FR2885528A1 (fr) 2006-11-17
EP1879621A2 (fr) 2008-01-23
US20090069425A1 (en) 2009-03-12
NO20076426L (no) 2008-02-08

Similar Documents

Publication Publication Date Title
WO2006110187A3 (en) Methods and compositions for the treatment of anxiety disorders
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
WO2008011363A3 (en) Quercetin-containing compositions
BRPI0607017B8 (pt) composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
EA200802428A1 (ru) Комбинации агентов для биологической борьбы и нематоцидов, входящих в покрытие семян
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
WO2007142755A3 (en) Purine analogs
WO2007095050A3 (en) N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase
ECSP099414A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA200900136A1 (ru) Пирролопиримидины для фармацевтических композиций
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
EA200700909A1 (ru) Азаиндолкарбоксамиды
EA200802054A1 (ru) Ингибиторы фермента
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
EA200701995A1 (ru) Способы уменьшения кальцификации
HK1125040A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
EA200900783A1 (ru) Соединения и композиции в качестве ингибиторов киназы
WO2006123031A3 (fr) Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l’un de ses derives a l'etat solubilise
WO2006081516A3 (en) USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
HK1139309A1 (en) Thioxanthene derivates usefulto treat infectious diseases
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos